Dr. Isabel Newton Named CMO for Boston Scientific’s Interventional Oncology and Embolization Business

February 3, 2026—Isabel Newton, MD, PhD, has been named Chief Medical Officer of Boston Scientific's Interventional Oncology and Embolization business.

The company shared that Dr. Newton is a board-certified diagnostic and interventional radiologist with deep clinical, academic, leadership, and research experience in oncology. Her research has focused on liver cancer, including cancer stem cells, cryoablation, and immuno-oncology.

Boston Scientific notes that Dr. Newton previously served as Chief of Interventional Radiology at the Veterans Affairs San Diego Health Care System in San Diego, California, and as a professor at University of California, San Diego Health, where she also held leadership roles in faculty development and wellness.

Additionally, Dr. Newton is Cofounder and Chair of the Interventional Initiative, a nonprofit organization that promotes minimally invasive, image-guided care.

“I am thrilled to be joining Boston Scientific as the chief medical officer for Interventional Oncology & Embolization,” Dr. Newton posted on LinkedIn. “BSC has been with IRs since the beginning and continues to innovate in ways that give our patients more options and a better quality of life. By joining this winning team, I will have new opportunities to push the frontiers of minimally invasive treatments for cancers and life-altering diseases.”

Boston Scientific advised that its portfolio of cancer and embolization products includes the Embold detachable coil system, which recently received CE Mark approval in Europe; a hepatic artery infusion therapy, which it obtained through the 2025 acquisition of Intera Oncology; and TheraSphere Y-90 glass microspheres for the treatment of primary liver cancer.

In April 2023, Endovascular Today published an interview with Dr. Newton in which she discussed public and health care system awareness of interventional radiology and embolotherapies, and a 2017 Q&A featured the founders of the Interventional Initiative sharing insights into its goals and progress to date.